In the context of GC, it has been documented that the presence of SULF1 is correlated with an unfavorable prognosis and an increased risk of lymph node metastases, while several researchers demonstrated that SULF1 inhibited GC cells proliferation and invasion [25, 26]. This evidence concerns the gene SULF1 and gastric cancer.